Showing results (11-20 of 670) with videos related to
Sort By:
Pageof 67
Nutrition and Metabolism|January 1, 1980
Oral and parenteral nutrition with L-Valine: mode of actionP Riederer, K Jellinger, G Kleinberger, et al.Journal of Neural Transmission. Supplementum|January 1, 1987
Cellular action of MAO inhibitorsC Konradi, P Riederer, K Jellinger, et al.Journal of Neural Transmission. Supplementum|January 1, 1991
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosisP Riederer, K W Lange, J Kornhuber, et al.Neuroscience Letters|August 17, 1992
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's diseaseE Sofic, K W Lange, K Jellinger, et al.Journal of Neural Transmission. Supplementum|January 1, 1978
Brain monoamines in hepatic encephalopathy and other types of metabolic comaK Jellinger, P Riederer, W D Rausch, et al.Journal of Neurochemistry|November 1, 1990
Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defectP Lestienne, J Nelson, P Riederer, et al.Infusionstherapie Und Klinische Ernahrung|February 1, 1985
[Changes in and modulation of receptor activity in hepatic encephalopathy]E Kienzl, P Riederer, T Brücke, et al.Mechanisms of Ageing and Development|September 1, 1980
Levodopa in the treatment of (pre) senile dementiaK Jellinger, H Flament, P Riederer, et al.Acta Neuropathologica|July 21, 1999
The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissueJ Kornhuber, K Jellinger, J Wiltfang, et al.Journal of Neural Transmission. Supplementum|January 1, 1983
General properties of 14C-L-Valine-binding to human brain tissueP Riederer, E Kienzl, K Jellinger, et al.Pageof 67